PRPF8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.643400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.734400E-01
Normal-vs-Stage2
1.112410E-01
Normal-vs-Stage3
6.200400E-02
Normal-vs-Stage4
4.528600E-01
Stage1-vs-Stage2
3.548600E-01
Stage1-vs-Stage3
1.042610E-01
Stage1-vs-Stage4
6.394600E-01
Stage2-vs-Stage3
1.384640E-01
Stage2-vs-Stage4
5.842000E-01
Stage3-vs-Stage4
6.177900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.711400E-01
Normal-vs-AfricanAmerican
7.905200E-01
Normal-vs-Asian
8.808100E-02
Caucasian-vs-AfricanAmerican
2.297200E-01
Caucasian-vs-Asian
2.946800E-01
AfricanAmerican-vs-Asian
3.313600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.870810E-01
Normal-vs-Female
3.756200E-01
Male-vs-Female
3.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.615800E-01
Normal-vs-Age(41-60Yrs)
6.022000E-01
Normal-vs-Age(61-80Yrs)
1.406380E-01
Normal-vs-Age(81-100Yrs)
4.482200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.485000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.223200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.674200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.099900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.117400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.075700E-02
Normal-vs-Daily Drinker
5.370300E-02
Normal-vs-Weekly Drinker
2.551600E-01
Normal-vs-Occasional Drinker
5.744000E-01
Normal-vs-Social Drinker
8.490800E-01
Non Drinker-vs-Daily Drinker
8.271400E-01
Non Drinker-vs-Weekly Drinker
4.381800E-01
Non Drinker-vs-Occasional Drinker
8.271900E-02
Non Drinker-vs-Social Drinker
7.388100E-02
Daily Drinker-vs-Weekly Drinker
4.148600E-01
Daily Drinker-vs-Occasional Drinker
6.239600E-02
Daily Drinker-vs-Social Drinker
6.579600E-02
Weekly Drinker-vs-Occasional Drinker
3.820400E-01
Weekly Drinker-vs-Social Drinker
2.352800E-01
Occasional Drinker-vs-Social Drinker
6.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.735200E-01
Normal-vs-Grade 2
8.159000E-01
Normal-vs-Grade 3
8.449200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.727660E-02
Grade 1-vs-Grade 3
4.778200E-02
Grade 1-vs-Grade 4
9.735200E-01
Grade 2-vs-Grade 3
3.712400E-01
Grade 2-vs-Grade 4
8.159000E-01
Grade 3-vs-Grade 4
8.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.105900E-02
Normal-vs-NonDiabetic
3.035800E-01
Diabetic-vs-NonDiabetic
1.924770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.046560E-01
Normal-vs-NoPancreatitis
2.562600E-01
Pancreatitis-vs-NoPancreatitis
6.964600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.564400E-01
Normal-vs-N1
1.102580E-01
N0-vs-N1
1.253030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.019900E-02
Normal-vs-TP53-NonMutant
7.875800E-01
TP53-Mutant-vs-TP53-NonMutant
6.229700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
